{"prompt": "['1979.35(3): p. 549-56.', 'Pinkawa, M., et al., Health-related quality of life after adjuvant and salvage postoperative', 'radiotherapy for prostate cancer - a prospective analysis. Radiother Oncol, 2008. 88(1):', 'p. 135-9.', 'Pollack, A., et al., Dosimetry and preliminary acute toxicity in the first 100 men treated for', 'prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat', 'Oncol Biol Phys, 2006. 64(2): p. 518-26.', 'Pollack, A., Walker, G., Buyyounouski, M., Horwitz, E., Price, R., Feigenberg, S., Konski, A.,', 'Stoyanova, R., Ma, C., Five Year Results of a Randomized External Beam Radiotherapy', 'Hypofractionation Trial for Prostate Cancer int J Radiat Oncol Biol Phys, 2011. 81(2):', 'p. S1.', 'Prostate Cancer (Version 2.2016). 2014 [cited 2016 May 17]; Available from:', 'tp://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.', 'Proust-Lima, C., et al., Confirmation of a low alpha/beta ratio for prostate cancer treated by', 'external beam radiation therapy alone using a post-treatment repeated-measure model', 'for PSA dynamics. Int J Radiat Oncol Biol Phys, 2011. 79(1): p. 195-201.', 'Rizopoulos D. Joint models for longitudinal and time-to-event data with applications in R. Boca', 'Raton, FL: Chapman & Hall/CRC; 2012.', 'Roach M 3rd, DeSilvio M, Lawton C, Uhl V, Machtay M, Seider MJ, Rotman M, Jones C,', 'Asbell SO, Valicenti RK, Han S, Thomas CR Jr, Shipley WS; Phase III trial comparing', 'whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant', 'combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin', 'Oncol. 2003 May 15;21(10):1904-11.', 'Shipley, J.W., et al., Initial Report of RTOG 9601: A Phase III Trial in Prostate Cancer: Anti-', 'androgen Therapy (AAT) with Bicalutamide during and after Radiation Therapy (RT)', 'Improves Freedom from Progression and Reduces the Incidence of Metastatic Disease in', 'Patients following Radical Prostatectomy (RP) with pT2-3, NO Disease, and Elevated', 'PSA Levels. International Journal of Radiation Oncology Biology Physics, 2010. 78(3): p.', 's27.', 'Sineshaw HM, Gray PJ, Efstathiou JA, Jemal A. Declining Use of Radiotherapy for Adverse', 'Features After Radical Prostatectomy: Results From the National Cancer Data Base. Eur', 'Urol. 2015 Nov;68(5):768-74. doi: 10.1016/j.eururo.2015.04.003. Epub 2015 Apr 18.', 'PubMed PMID: 25896124.', 'Smith, B.D., et al., Fractionation for whole breast irradiation: an American Society for', 'Radiation Oncology (ASTRO) evidence-based guideline. int J Radiat Oncol Biol Phys,', '2011.81(1): p. 59-68.', 'Stephenson, A.J., et al., Defining biochemical recurrence of prostate cancer after radical', 'NRG-GU003', '53', 'Version Date: April 26, 2019']['prostatectomy: a proposal for a standardized definition. J Clin Oncol, 2006. 24(24): p.', '3973-8.', 'Stephenson, A.J., et al., Postoperative radiation therapy for pathologically advanced prostate', 'cancer after radical prostatectomy. Eur Urol, 2012. 61(3): p. 443-51.', 'Stephenson, A.J., et al., Predicting the outcome of salvage radiation therapy for recurrent', 'prostate cancer after radical prostatectomy. J Clin Oncol, 2007. 25(15): p. 2035-41.', 'Stephenson, A.J., et al., Salvage radiotherapy for recurrent prostate cancer after radical', 'prostatectomy. JAMA, 2004. 291(11): p. 1325-32.', 'Swanson, G.P., et al., Predominant treatment failure in post-prostatectomy patients is local:', 'analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol, 2007. 25(16): p.', '2225-9.', 'Swanson, G.P., et al., Update of SWOG 8794: Adjuvant Radiotherapy for pT3 Prostate Cancer', 'Improves Metastasis Free Survival. Int J Radiat Biol, 2008. 72(1): p. S3.', 'Tewari, A., et al., Positive surgical margin and perioperative complication rates of primary', 'surgical treatments for prostate cancer: a systematic review and meta-analysis', 'comparing retropubic, laparoscopic, and robotic prostatectomy. Eur Urol, 2012. 62(1):', 'p. 1-15.', 'Thompson, I.M., et al. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO', 'Guideline. J Urol. 2013. 190(2):441-9. Epub 2013 May 21.', 'Thompson, I.M., et al., Adjuvant radiotherapy for pathological T3N0M0 prostate cancer', 'significantly reduces risk of metastases and improves survival: long-term followup of a', 'randomized clinical trial. J Urol, 2009. 181(3): p. 956-62.', 'Thompson, I.M., Jr., et al., Adjuvant radiotherapy for pathologically advanced prostate cancer:', 'a randomized clinical trial. Jama, 2006. 296(19): p. 2329-35.', 'Valicenti, R.K., et al., Effect of higher radiation dose on biochemical control after radical', 'prostatectomy for PT3NO prostate cancer. int J Radiat Oncol Biol Phys, 1998. 42(3): p.', '501-6.', 'Van der Kogel, A. and M. Joiner, Basic Clinical Radiobiology2009: Hodder Arnold.', 'Van Der Poel, H.G., L. Moonen, and S. Horenblas, Sequential treatment for recurrent localized', 'prostate cancer. J Surg Oncol, 2008. 97(5): p. 377-82.', 'Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York, NY:', 'Springer-Verlag; 2000.', 'Vogelius, I.R. and S.M. Bentzen, Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in', 'the Presence of an Overall Time Factor: Bad News, Good News, or No News? int J', 'NRG-GU003', '54', 'Version Date: April 26, 2019']\n\n###\n\n", "completion": "END"}